35 related articles for article (PubMed ID: 25056425)
1. Defining the optimal prognostic window for cardiopulmonary exercise testing in patients with heart failure.
Arena R; Myers J; Abella J; Pinkstaff S; Brubaker P; Kitzman D; Peberdy MA; Bensimhon D; Chase P; Forman DE; Guazzi M
Circ Heart Fail; 2010 May; 3(3):405-11. PubMed ID: 20200329
[TBL] [Abstract][Full Text] [Related]
2. Depressive symptoms, right ventricular function, and muscular strength are associated with peak oxygen uptake in patients with implantable left ventricular assist devices.
Kitagaki K; Aoki T; Miura H; Shimada Y; Konishi H; Tsukamoto Y; Noguchi T
Artif Organs; 2024 Feb; 48(2):166-174. PubMed ID: 37921338
[TBL] [Abstract][Full Text] [Related]
3. Independent and Added Value of Cardiopulmonary Exercise Testing to New York Heart Association Classification in Patients With Heart Failure.
de Souza IPMA; Ramos JVSP; da Silveira AD; Stein R; Ribeiro RS; Pazelli AM; de Oliveira QB; Darzé ES; Ritt LEF
J Cardiopulm Rehabil Prev; 2024 Jul; 44(4):266-272. PubMed ID: 38709847
[TBL] [Abstract][Full Text] [Related]
4. Estimating maximum work rate during cardiopulmonary exercise testing from the six-minute walk distance in patients with heart failure.
Piaggi G; Paneroni M; Maestri R; Salvioni E; Corrà U; Caporotondi A; Scalvini S; Agostoni P; La Rovere MT
Int J Cardiol Cardiovasc Risk Prev; 2024 Jun; 21():200247. PubMed ID: 38496329
[TBL] [Abstract][Full Text] [Related]
5. Cardiorespiratory optimal point: a submaximal exercise variable to assess panic disorder patients.
Ramos PS; Sardinha A; Nardi AE; de Araújo CG
PLoS One; 2014; 9(8):e104932. PubMed ID: 25157496
[TBL] [Abstract][Full Text] [Related]
6. Relationship of maximum walking speed with peak oxygen uptake and anaerobic threshold in male patients with heart failure.
Koen M; Kubota Y; Tokita M; Kato K; Takahashi H; Akutsu K; Asai K; Takano H
Heart Vessels; 2023 Nov; 38(11):1344-1355. PubMed ID: 37493799
[TBL] [Abstract][Full Text] [Related]
7. Effects of beta-hydroxy beta-methyl butyrate calcium combined with exercise therapy in patients with cardiac disease: a study protocol for clinical trial.
Ikeda T; Miyazawa R; Inoue E; Iso Y; Nakamura D; Abe S; Hachisu M; Tashiro N; Iguchi A; Aimoto K; Nakamura S; Ichikawa H
BMJ Open; 2023 Feb; 13(2):e066633. PubMed ID: 36754563
[TBL] [Abstract][Full Text] [Related]
8. Development and appropriateness of a scoring method for International Classification of Functioning, Disabilities, and Health assessment in older patients with heart failure: a Delphi survey of expert panel in Japan.
Shiota S; Kitagawa T; Goto N; Fujisita H; Tamekuni Y; Nakayama S; Mio N; Kanai K; Naka M; Yamaguchi M; Mochizuki M; Ochikubo H; Hidaka T; Yasunobu Y; Nakano Y; Kihara Y; Kimura H
BMJ Open; 2022 Sep; 12(9):e060609. PubMed ID: 36115681
[TBL] [Abstract][Full Text] [Related]
9. Association of adherence to a 3 month cardiac rehabilitation with long-term clinical outcomes in heart failure patients.
Nakanishi M; Miura H; Irie Y; Nakao K; Fujino M; Otsuka F; Aoki T; Yanase M; Goto Y; Noguchi T
ESC Heart Fail; 2022 Apr; 9(2):1424-1435. PubMed ID: 35142087
[TBL] [Abstract][Full Text] [Related]
10. Effect of Exercise Training in Heart Failure Patients Without Echocardiographic Response to Cardiac Resynchronization Therapy.
Yanagi H; Nakanishi M; Konishi H; Yamada S; Fukui N; Kitagaki K; Fujii S; Kohzuki M
Circ Rep; 2019 Jan; 1(2):55-60. PubMed ID: 33693114
[No Abstract] [Full Text] [Related]
11. Protein acetylation in skeletal muscle mitochondria is involved in impaired fatty acid oxidation and exercise intolerance in heart failure.
Tsuda M; Fukushima A; Matsumoto J; Takada S; Kakutani N; Nambu H; Yamanashi K; Furihata T; Yokota T; Okita K; Kinugawa S; Anzai T
J Cachexia Sarcopenia Muscle; 2018 Oct; 9(5):844-859. PubMed ID: 30168279
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of cardiopulmonary exercise testing in heart failure with preserved ejection fraction. The Henry Ford HospITal CardioPulmonary EXercise Testing (FIT-CPX) project.
Shafiq A; Brawner CA; Aldred HA; Lewis B; Williams CT; Tita C; Schairer JR; Ehrman JK; Velez M; Selektor Y; Lanfear DE; Keteyian SJ
Am Heart J; 2016 Apr; 174():167-72. PubMed ID: 26995385
[TBL] [Abstract][Full Text] [Related]
13. Greater prognostic value of peak VO2 after exercise training program completion in heart failure patients.
Tabet JY; Meurin P; Benzidi Y; Beauvais F; Ben Driss A; Weber H; Renaud N; Dumaine R; Grosdemouge A; Cohen Solal A
Int J Cardiol; 2013 Oct; 168(4):4139-44. PubMed ID: 23911267
[TBL] [Abstract][Full Text] [Related]
14. A meta-analysis of the prognostic significance of cardiopulmonary exercise testing in patients with heart failure.
Cahalin LP; Chase P; Arena R; Myers J; Bensimhon D; Peberdy MA; Ashley E; West E; Forman DE; Pinkstaff S; Lavie CJ; Guazzi M
Heart Fail Rev; 2013 Jan; 18(1):79-94. PubMed ID: 22733204
[TBL] [Abstract][Full Text] [Related]
15. The impact of pharmacotherapy on the cardiopulmonary exercise test response in patients with heart failure: a mini review.
Guazzi M; Arena R
Curr Vasc Pharmacol; 2009 Oct; 7(4):557-69. PubMed ID: 19485908
[TBL] [Abstract][Full Text] [Related]
16. Targeting of high peak respiratory exchange ratio is safe and enhances the prognostic power of peak oxygen uptake for heart failure patients.
Nakanishi M; Takaki H; Kumasaka R; Arakawa T; Noguchi T; Sugimachi M; Goto Y
Circ J; 2014; 78(9):2268-75. PubMed ID: 25056425
[TBL] [Abstract][Full Text] [Related]
17. Cardiopulmonary exercise testing as prognostic indicators: Comparisons among heart failure patients with reduced, mid-range and preserved ejection fraction.
Sato T; Yoshihisa A; Kanno Y; Suzuki S; Yamaki T; Sugimoto K; Kunii H; Nakazato K; Suzuki H; Saitoh SI; Ishida T; Takeishi Y
Eur J Prev Cardiol; 2017 Dec; 24(18):1979-1987. PubMed ID: 29086584
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
